CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388971%3A_____%2F10%3A00350375" target="_blank" >RIV/61388971:_____/10:00350375 - isvavai.cz</a>

Alternative codes found

RIV/00023728:_____/10:#0000117 RIV/00023728:_____/10:#0000021

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis

Original language description

High levels of CD161 receptor of NK cells are correlated with impairment of NK cytotoxic activity in RA patients. We propose that MCV plays an important role in RA by increasing expression of CD161, which leads to inhibition of NK cell activity and, consequently, insufficient downregulation of autoreactive T cell, thus accelerating disease progression

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

EC - Immunology

OECD FORD branch

—

Project

Result was created during the realization of more than one project. More information in the Projects tab.

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year

2010

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Clinical Immunology

ISSN

1521-6616

e-ISSN

—

Volume of the periodical

136

Issue of the periodical within the volume

1

Country of publishing house

US - UNITED STATES

Number of pages

9

Pages from-to

—

UT code for WoS article

000278954300015

EID of the result in the Scopus database

—